Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Hannah R. Whittaker"'
Autor:
Emily L. Graul, Clementine Nordon, Kirsty Rhodes, Shruti Menon, Mahmoud Al Ammouri, Constantinos Kallis, Anne E. Ioannides, Hannah R. Whittaker, Nicholas S. Peters, Jennifer K. Quint
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background An immediate, temporal risk of heart failure and arrhythmias after a Chronic Obstructive Pulmonary Disease (COPD) exacerbation has been demonstrated, particularly in the first month post-exacerbation. However, the clinical profile
Externí odkaz:
https://doaj.org/article/5d521aa9554c49409c83e9d38dbcea4c
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Randomised control trials (RCTs) with strict eligibility criteria can lead to trial populations not commonly seen in clinical practice. We described the proportion of people with chronic obstructive pulmonary disease (COPD) in Eng
Externí odkaz:
https://doaj.org/article/5f7243ced3fd47fba8b22a8ad074266d
Autor:
Ardita Koteci, Ann D. Morgan, Laura Portas, Hannah R. Whittaker, Constantinos Kallis, Peter M. George, Jennifer K. Quint
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Cardiovascular disease is prevalent in idiopathic pulmonary fibrosis (IPF), yet the extent of left-sided heart failure (HF) burden, whether this has changed with time and whether HF impacts mortality risk in these patients are unk
Externí odkaz:
https://doaj.org/article/3c6fbd9c9260466db61835af4dd15c06
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-12 (2019)
Abstract Rate of FEV1 decline in COPD is heterogeneous and the extent to which inhaled corticosteroids (ICS) influence the rate of decline is unclear. The majority of previous reviews have investigated specific ICS and non-ICS inhalers and have consi
Externí odkaz:
https://doaj.org/article/d17d24371afb4f63b765d2eaf9d813e6
Publikováno v:
Annals of the American Thoracic Society. 19(11)
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 15:3079-3091
Background Estimates for lung function decline in chronic obstructive pulmonary disease (COPD) have differed by study setting and have not been described in a UK primary care population. Purpose To describe rates of FEV1 and FVC decline in COPD and i
Autor:
Maria Guzman-Castillo, Jonathan Pearson-Stuttard, Piotr Bandosz, Eric J. Brunner, Brendan Collins, Sara Ahmadi-Abhari, Simon Capewell, Martin O'Flaherty, Martin J. Shipley, Hannah R Whittaker
Publikováno v:
Diabetologia
Aims/hypothesis Diabetes is associated with an increased risk of dementia. We estimated the potential impact of trends in diabetes prevalence upon mortality and the future burden of dementia and disability in England and Wales. Methods We used a prob
Autor:
Hannah R Whittaker, Claudia Gulea, Ardita Koteci, Constantinos Kallis, Ann D Morgan, Chukwuma Iwundu, Mark Weeks, Rikisha Gupta, Jennifer K Quint
Publikováno v:
BMJ (Clinical research ed.). 375
ObjectivesTo describe the rates for consulting a general practitioner (GP) for sequelae after acute covid-19 in patients admitted to hospital with covid-19 and those managed in the community, and to determine how the rates change over time for patien
Publikováno v:
Pragmatic and Observational Research
Hannah R Whittaker,1 Steven J Kiddle,2 Jennifer K Quint1 1National Heart and Lung Institute, Imperial College London, London, UK; 2MRC Biostatistics Unit, University of Cambridge, Cambridge, UKCorrespondence: Hannah R Whittaker Email h.whittaker@impe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::854743c37e465aec48c680472c80b8fd